Panacea Biotec Limited
NSE:PANACEABIO.NS
317.89 (INR) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Panacea Biotec Limited |
Symbool | PANACEABIO.NS |
Munteenheid | INR |
Prijs | 317.89 |
Beurswaarde | 19,470,985,023 |
Dividendpercentage | 0% |
52-weken bereik | 112.35 - 317.89 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Rajesh Jain Ph.D. |
Website | https://www.panaceabiotec.com |
An error occurred while fetching data.
Over Panacea Biotec Limited
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)